ID
34747
Description
Study ID: 101998 Clinical Study ID: 101998 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor GlaxoSmithKline Collaborators N/A Phase Phase 3 Study Recruitment Status Completed Generic Name sumatriptan Trade Name Imitrex ,Imiject ,Imigran Study Indication Migraine Disorders The purpose of this form is to document the subjects study participation status. It should be filled out at the screening visit.
Keywords
Versions (3)
- 1/18/19 1/18/19 -
- 1/23/19 1/23/19 -
- 1/26/19 1/26/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
January 26, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Efficacy and Tolerability of TREXIMA Tablets vs. Placebo During Mild Migraine Study ID 101998
Study Participation Status
- StudyEvent: ODM
Description
Randomisation Number
Alias
- UMLS CUI-1
- C0034656
- UMLS CUI-2
- C0237753
Description
Investigational Product Container Number
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C0180098
- UMLS CUI-3
- C0600091
Description
Previous Clinical Trial Participation (Migraine Treatment)
Alias
- UMLS CUI-1
- C2348568
- UMLS CUI-2
- C0149931
- UMLS CUI-3
- C0087111
Description
Previous Clinical Trial Participation (Migraine Treatment)
Data type
text
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C0149931
- UMLS CUI [1,3]
- C0087111
Description
Number of Research Studies
Data type
integer
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1265611
Description
PRIOR PARTICIPATION IN SUMATRIPTAN 85MG / NAPROXEN SODIUM 500MG TABLET STUDIES
Alias
- UMLS CUI-1
- C2348568
- UMLS CUI-2
- C0075632
- UMLS CUI-3
- C0027396
Description
Previous Administrative Data
Alias
- UMLS CUI-1
- C1320722
- UMLS CUI-2
- C0205156
Description
Study Number
Data type
integer
Alias
- UMLS CUI [1,1]
- C0008976
- UMLS CUI [1,2]
- C0600091
Description
Previous Protocol Number
Data type
text
Alias
- UMLS CUI [1,1]
- C3274381
- UMLS CUI [1,2]
- C0205156
Description
Previous Centre Number
Data type
integer
Alias
- UMLS CUI [1,1]
- C0600091
- UMLS CUI [1,2]
- C0019994
- UMLS CUI [1,3]
- C0205156
Description
Previous Subject Number
Data type
integer
Alias
- UMLS CUI [1,1]
- C2348585
- UMLS CUI [1,2]
- C0205156
Similar models
Study Participation Status
- StudyEvent: ODM
C0237753 (UMLS CUI [1,2])
C0180098 (UMLS CUI-2)
C0600091 (UMLS CUI-3)
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C0149931 (UMLS CUI-2)
C0087111 (UMLS CUI-3)
C0149931 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0075632 (UMLS CUI-2)
C0027396 (UMLS CUI-3)
C0075632 (UMLS CUI [1,2])
C0027396 (UMLS CUI [1,3])
C0205156 (UMLS CUI-2)
C0205156 (UMLS CUI [1,2])
C0019994 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0205156 (UMLS CUI [1,2])
No comments